Customer Guest RE-KYC
please type the captcha code.
Register|Generate Password|Dos and Don'ts of Demat Account
For Login related queries e-mail: emkayassist@emkayglobal.com
"Attention Investors
1. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. 2. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. 3. Pay 20% upfront margin of the transaction value to trade in cash market segment. 4. Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard. 5. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month. 6.Investor Charter 7.Disclosure of Complaints 8.COMPLAINTS / SCORES
.......... Issued in the interest of Investors"
Regenerate OTP
Please contact to emkayassist@emkayglobal.com
Please select Mobile No and Email Id for OTP
Customer Guest
Login | Register
Login | Register|Forgot password?
Bal Pharma Limited has informed the Exchange regarding Intimation to physical shareholders to update KYC.more...
We are submitting to the exchange a copy of the intimation sent to our physical shareholders for updating their KYC.more...
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1 Name of Company Bal Pharma Ltd 2 ...more...
BAL PHARMA LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agentmore...
BAL PHARMA LIMITED has informed the Exchange regarding Outcome of Board Meeting held on 29-May-2025 for Dividendmore...
Bal Pharma Limited has informed the Exchange about Copy of Newspaper Publicationmore...
The company reported standalone net profit of Rs 5.61 crore for the quarter ended March 31 2025 as compared to Rs 6.22 crore in the same period last ...more...
Bal Pharma Limited has submitted to the Exchange the Audited financial results for the period ended March 31 2025 and recommend a dividend o...more...
Bal Pharma Limited has informed the Exchange that Board of Directors at its meeting held on May 29 2025 1. Approved the audited financial results ( s...more...
Board of Directors at their meeting held on 29.05.2025 has inter alia approved \r\n\r\n1. Audited financial results for the financial year e...more...
Bal Pharma Limited has informed the Exchange regarding Resignation of Mr.Kotian Chittanand Damodar (DIN # 09613054) - Executive Director of the compa...more...
Mr.Kotain Chittanand Damodar (DIN # 09613054) has tendered his resignation as Whole Time Director of the Company w.e.f 16.05.2025 citing personal rea...more...
BAL PHARMA LIMITED has informed the Exchange about Board Meeting to be held on 29-May-2025 to consider and approve the Yearly Audited Financ...more...
Bal Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2025 inter alia to consider and approv...more...
Bal Pharma Limited has informed the Exchange regarding Change in Director(s) of the company.more...
The Board of Directors of the Company through a resolution passed by circulation has appointed Mr.Ravindra Kumar Kothari ( DIN # 03418320) as Additio...more...
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1 Name of Company Bal Phar...more...
As per the provisions of Regulation 31A of SEBI(LODR) Regulations we are herewith withdrawing our application for reclassification of promoters.more...
Bal Pharma Limited has informed the Exchange about update on its application for reclassification of promoters.more...
Enter Stock
BOARD MEETINGS Company Name : Kuberan Global Edu Date : 24-06-2025